IVF HARTMANN Holding AG Logo

IVF HARTMANN Holding AG

Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.

VBSN | SW

Overview

Corporate Details

ISIN(s):
CH0187624256
LEI:
Country:
Switzerland
Address:
Victor-von-Bruns-Strasse 28, 8212 Neuhausen am Rheinfall
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

IVF HARTMANN Holding AG is a Swiss-based holding company engaged in the production and distribution of medical supplies and consumer goods. As a leading manufacturer in Switzerland for over 150 years, the company serves as a key supplier to the national healthcare industry. Its product portfolio includes a wide range of medical, pharmaceutical, and hygiene items, such as wound care dressings, bandages, surgical disposables, first-aid supplies, and accident prevention products. The company provides these essential goods to both the Swiss market and internationally.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all IVF HARTMANN Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for IVF HARTMANN Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for IVF HARTMANN Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-08-23 N/A Non-Executive member Buy None 11,200.00 CHF
2023-08-21 N/A Non-Executive member Buy None 11,200.00 CHF

Peer Companies

Company Country Ticker View
InflaRx N.V. Logo
Develops complement system inhibitors for severe inflammatory diseases and immuno-dermatology.
United States of America IFRX
Inhibikase Therapeutics, Inc. Logo
Develops kinase inhibitors to treat neurodegenerative diseases like Parkinson's.
United States of America IKT
Inhibrx Biosciences, Inc. Logo
Clinical-stage biopharma developing novel biologic therapies for life-threatening cancers.
United States of America INBX
InMed Pharmaceuticals Inc. Logo
Develops cannabinoid drugs for unmet medical needs and supplies rare cannabinoids for B2B wellness.
United States of America INM
Inmune Bio, Inc. Logo
Develops immunotherapies reprogramming innate immunity for cancer, Alzheimer's, and inflammation.
United States of America INMB
Innate Pharma SA Logo
Developing first-in-class antibody immunotherapies for cancer via the innate immune system.
United States of America IPHA
INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America INO
Insight Molecular Diagnostics Inc. Logo
Develops molecular diagnostic tests for oncology and transplant monitoring for clinicians & researchers.
United States of America IMDX
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America TIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.